Sun Pharma settles patent dispute with Celgene over generic Revlimid Ruchika Sharma22 Jun 2021 12:24 PM ISTMumbai: Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 5:15 PM ISTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they...
Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US Ruchika Sharma12 Dec 2020 4:36 PM ISTAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
Dr Reddys settles patent litigation over cancer drug Revlimid with Celgene in US Ruchika Sharma19 Sept 2020 9:45 AM ISTRevlimid is used to treat multiple myeloma and myelodysplastic syndromes.
